These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6840176)

  • 1. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
    Ehrsson H; Wallin I; Nilsson SO; Johansson B
    Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of prednimustine and chlorambucil in the rat.
    Newell DR; Shepherd CR; Harrap KR
    Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
    Sayed A; Hove WV; Vermeulen A
    Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
    Loos U; Musch E; Malek M; Riedel E
    Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
    Hartley-Asp B; Gunnarsson PO; Liljekvist J
    Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of chlorambucil and prednimustine.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Dec; 16(6):762-3. PubMed ID: 6661370
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
    Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
    Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of orally administered 14C-prednimustine in cancer patients.
    Gaver RC; Deeb G; Pittman KA; Issell BF; Mittelman A; Smyth RD
    Cancer Chemother Pharmacol; 1983; 11(3):139-43. PubMed ID: 6640823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the clinical pharmacology of prednimustine.
    Plym Forshell G; Gunnarsson PO; Liljekvist J
    Br J Clin Pharmacol; 1983 Dec; 16(6):760-1. PubMed ID: 6661369
    [No Abstract]   [Full Text] [Related]  

  • 12. The antitumor effect of prednimustine in vitro and in vivo.
    Hartley-Asp B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
    Endresen L
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
    Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H
    Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednimustine treatment in malignant lymphomas.
    Szántó I; Fleischmann T; Eckhardt S
    Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary clinical study of prednimustine in lung cancer.
    Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
    J Med; 1977; 8(2):115-21. PubMed ID: 268397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
    Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
    Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some metabolic aspects of a nitrogen mustard of prednisolone.
    Kirdani RY; Murphy GP; Sandberg AA
    Oncology; 1978; 35(2):47-53. PubMed ID: 652263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.